Dimensional Fund Advisors LP Increases Position in Illumina, Inc. (NASDAQ:ILMN)

Dimensional Fund Advisors LP raised its position in shares of Illumina, Inc. (NASDAQ:ILMN) by 3.5% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 264,925 shares of the life sciences company’s stock after buying an additional 9,017 shares during the period. Dimensional Fund Advisors LP’s holdings in Illumina were worth $45,211,000 as of its most recent filing with the SEC.

Several other large investors have also made changes to their positions in the stock. Jennison Associates LLC boosted its stake in shares of Illumina by 69.0% in the first quarter. Jennison Associates LLC now owns 5,254,274 shares of the life sciences company’s stock worth $896,589,000 after buying an additional 2,144,576 shares during the period. Vanguard Group Inc. boosted its stake in shares of Illumina by 3.0% in the first quarter. Vanguard Group Inc. now owns 9,648,842 shares of the life sciences company’s stock valued at $1,646,479,000 after buying an additional 285,379 shares during the last quarter. TIAA CREF Investment Management LLC boosted its stake in shares of Illumina by 40.1% in the first quarter. TIAA CREF Investment Management LLC now owns 948,121 shares of the life sciences company’s stock valued at $161,787,000 after buying an additional 271,461 shares during the last quarter. Baird Financial Group Inc. boosted its stake in shares of Illumina by 1,110.5% in the first quarter. Baird Financial Group Inc. now owns 279,120 shares of the life sciences company’s stock valued at $47,629,000 after buying an additional 256,061 shares during the last quarter. Finally, Teachers Advisors LLC boosted its stake in shares of Illumina by 60.7% in the first quarter. Teachers Advisors LLC now owns 384,300 shares of the life sciences company’s stock valued at $65,577,000 after buying an additional 145,231 shares during the last quarter. 93.73% of the stock is owned by institutional investors.

Shares of Illumina, Inc. (NASDAQ:ILMN) opened at 173.88 on Thursday. Illumina, Inc. has a 1-year low of $119.37 and a 1-year high of $189.48. The company has a market capitalization of $25.39 billion, a price-to-earnings ratio of 35.19 and a beta of 0.84. The firm’s 50-day moving average is $175.83 and its 200-day moving average is $170.23.

Illumina (NASDAQ:ILMN) last posted its quarterly earnings data on Tuesday, April 25th. The life sciences company reported $0.64 earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.64. Illumina had a net margin of 30.75% and a return on equity of 21.21%. The firm had revenue of $598 million for the quarter, compared to the consensus estimate of $590.51 million. During the same quarter in the prior year, the company posted $0.71 earnings per share. The company’s revenue for the quarter was up 4.5% compared to the same quarter last year. Analysts forecast that Illumina, Inc. will post $3.63 earnings per share for the current fiscal year.

WARNING: “Dimensional Fund Advisors LP Increases Position in Illumina, Inc. (NASDAQ:ILMN)” was first reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this article on another website, it was copied illegally and reposted in violation of international copyright legislation. The original version of this article can be read at https://sportsperspectives.com/2017/07/20/dimensional-fund-advisors-lp-increases-position-in-illumina-inc-nasdaqilmn.html.

Several equities research analysts have weighed in on ILMN shares. Vetr cut shares of Illumina from a “strong-buy” rating to a “buy” rating and set a $188.84 price target for the company. in a research report on Monday, March 27th. Zacks Investment Research raised shares of Illumina from a “hold” rating to a “buy” rating and set a $191.00 price target for the company in a research report on Tuesday, April 4th. Leerink Swann reissued a “buy” rating on shares of Illumina in a research report on Wednesday, April 5th. TheStreet raised shares of Illumina from a “c+” rating to a “b” rating in a research report on Thursday, April 6th. Finally, Bank of America Corporation increased their price target on shares of Illumina from $175.00 to $195.00 and gave the company a “buy” rating in a research report on Tuesday, April 11th. Four investment analysts have rated the stock with a sell rating, ten have assigned a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the stock. Illumina currently has a consensus rating of “Hold” and a consensus target price of $166.54.

In other news, Director A Blaine Bowman sold 2,300 shares of the company’s stock in a transaction dated Wednesday, May 10th. The shares were sold at an average price of $181.61, for a total transaction of $417,703.00. Following the transaction, the director now owns 18,004 shares in the company, valued at $3,269,706.44. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, SVP Charles Dadswell sold 1,609 shares of the company’s stock in a transaction dated Wednesday, May 3rd. The shares were sold at an average price of $187.07, for a total transaction of $300,995.63. Following the transaction, the senior vice president now owns 10,936 shares in the company, valued at approximately $2,045,797.52. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 110,248 shares of company stock worth $19,720,123. Corporate insiders own 1.60% of the company’s stock.

About Illumina

Illumina, Inc (Illumina) is a provider of sequencing- and array-based solutions for genetic analysis. The Company operates through two segments: Core Illumina and the consolidated variable interest entities (VIEs), which include the activities of GRAIL, Inc (GRAIL) and Helix Holdings I, LLC (Helix). Core Illumina consists of its core operations.

Want to see what other hedge funds are holding ILMN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Illumina, Inc. (NASDAQ:ILMN).

Institutional Ownership by Quarter for Illumina (NASDAQ:ILMN)

Receive News & Ratings for Illumina Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Illumina Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply